title: Liraglutide and obesity: a review of the data so far.
abstract: The prevalence of obesity worldwide has nearly doubled since 1980 with current estimates of 2.1 billion in 2013. Overweight and obesity lead to numerous adverse conditions including type 2 diabetes, cardiovascular disease, stroke, and certain cancers. The worldwide spread of obesity and associated comorbidities not only threatens quality of life but also presents a significant economic burden. While bariatric surgery has proven to be a viable treatment option for the morbidly obese, there is clearly a need for less invasive alternatives. Recent research has suggested that long-acting analogs of the gut hormone, glucagon-like peptide 1 (GLP-1), may have potential as an antiobesity treatment. The GLP-1 receptor agonist, liraglutide (trade name Saxenda), was recently approved by the US Food and Drug Administration as an obesity treatment option and shown in clinical trials to be effective in reducing and sustaining body weight loss. This review presents the basis for GLP-1-based therapies with a specific focus on animal and human studies examining liraglutide's effects on food intake and body weight.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Ellen E
authors.initials: EE
authors.lastname: Ladenheim
mesh_terms: D000818:Animals; D006801:Humans; D000069450:Liraglutide / Q000008:administration & dosage / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
chemical_list: D000069450:Liraglutide; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
keywords: exenatide; glucagon-like peptide 1; liraglutide; obesity
references.citation: Lancet. 2010 Aug 21;376(9741):595-605
references.pmid: 20673995
references.citation: Expert Opin Pharmacother. 2010 Aug;11(12):1971-82
references.pmid: 20569086
references.citation: Clin Ther. 2012 Jun;34(6):1247-1258.e22
references.pmid: 22608780
references.citation: Obesity (Silver Spring). 2011 Jul;19(7):1342-9
references.pmid: 21415845
references.citation: Lancet Diabetes Endocrinol. 2014 Apr;2(4):289-297
references.pmid: 24703047
references.citation: Endocrinology. 2008 Aug;149(8):4059-68
references.pmid: 18420740
references.citation: Diabetes Ther. 2014 Dec;5(2):367-83
references.pmid: 25027491
references.citation: J Hypertens. 1998 Dec;16(12 Pt 2):2013-7
references.pmid: 9886891
references.citation: Diabetologia. 2005 Apr;48(4):612-5
references.pmid: 15759106
references.citation: Diabetes Obes Metab. 2012 Jun;14(6):531-8
references.pmid: 22226053
references.citation: JAMA. 2010 Jan 20;303(3):235-41
references.pmid: 20071471
references.citation: Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1314-20
references.pmid: 23612998
references.citation: Acta Pharmacol Sin. 2012 Feb;33(2):194-200
references.pmid: 22301859
references.citation: J Pept Sci. 2012 Jun;18(6):383-93
references.pmid: 22565812
references.citation: Endocrinology. 1996 Jul;137(7):2968-78
references.pmid: 8770921
references.citation: Neuropharmacology. 2012 Apr;62(5-6):1916-27
references.pmid: 22227019
references.citation: Cell Metab. 2011 Mar 2;13(3):320-30
references.pmid: 21356521
references.citation: JAMA. 2010 Jan 20;303(3):242-9
references.pmid: 20071470
references.citation: Endocrinology. 2009 Jun;150(6):2654-9
references.pmid: 19264875
references.citation: J Hypertens. 2002 Nov;20(11):2257-67
references.pmid: 12409965
references.citation: J Neurosci. 2014 May 14;34(20):6985-92
references.pmid: 24828651
references.citation: Diabetes. 2014 Dec;63(12):4186-96
references.pmid: 25071023
references.citation: Endocrinology. 2009 Apr;150(4):1680-7
references.pmid: 19074583
references.citation: BMC Public Health. 2009 Mar 25;9:88
references.pmid: 19320986
references.citation: Obesity (Silver Spring). 2009 Jan;17(1):30-9
references.pmid: 18997675
references.citation: Endocrinology. 1995 Aug;136(8):3585-96
references.pmid: 7628397
references.citation: Drug Des Devel Ther. 2014 Sep 18;8:1419-27
references.pmid: 25258511
references.citation: Neuroendocrinology. 2011;94(4):291-301
references.pmid: 21893952
references.citation: Acta Diabetol. 2015 Apr;52(2):331-6
references.pmid: 25218924
references.citation: Lancet. 2008 Feb 16;371(9612):569-78
references.pmid: 18280327
references.citation: J Am Soc Hypertens. 2009 Jul-Aug;3(4):245-59
references.pmid: 20409967
references.citation: Endocrinology. 2009 Jul;150(7):2997-3001
references.pmid: 19389830
references.citation: Lancet. 2011 Aug 27;378(9793):815-25
references.pmid: 21872750
references.citation: Int J Obes (Lond). 2015 May;39(5):834-41
references.pmid: 25287751
references.citation: Endocrinology. 2005 Sep;146(9):3748-56
references.pmid: 15932924
references.citation: Am J Clin Nutr. 2012 Feb;95(2):297-308
references.pmid: 22158731
references.citation: Diabetol Metab Syndr. 2014 Sep 08;6(1):95
references.pmid: 25237400
references.citation: Ann N Y Acad Sci. 2014 Apr;1311:1-13
references.pmid: 24641701
references.citation: Nature. 1996 Jan 4;379(6560):69-72
references.pmid: 8538742
references.citation: J Med Chem. 2000 May 4;43(9):1664-9
references.pmid: 10794683
references.citation: N Engl J Med. 2004 Jun 3;350(23):2362-74
references.pmid: 15175438
references.citation: Hum Reprod Update. 2011 Jul-Aug;17(4):495-500
references.pmid: 21335359
references.citation: Brain Res. 2005 May 17;1044(1):127-31
references.pmid: 15862798
references.citation: Int J Obes (Lond). 2014 Jun;38(6):784-93
references.pmid: 23999198
references.citation: Int J Obes (Lond). 2015 Jan;39(1):187
references.pmid: 25311036
references.citation: EMBO Mol Med. 2015 Feb 04;7(3):288-98
references.pmid: 25652173
references.citation: Endocrinology. 1999 Jan;140(1):244-50
references.pmid: 9886831
references.citation: Lancet. 2013 Jan 12;381(9861):117-24
references.pmid: 23141817
references.citation: Endocrinology. 2010 Apr;151(4):1473-86
references.pmid: 20203154
references.citation: Diabetes. 1994 Apr;43(4):535-9
references.pmid: 8138058
references.citation: J Endocrinol. 2014 Mar 07;221(1):T1-16
references.pmid: 24323912
references.citation: J Clin Invest. 2014 Oct;124(10):4473-88
references.pmid: 25202980
references.citation: Lancet. 2014 Aug 30;384(9945):766-81
references.pmid: 24880830
references.citation: Physiol Rev. 2007 Oct;87(4):1409-39
references.pmid: 17928588
references.citation: Front Neurosci. 2013 Oct 14;7:181
references.pmid: 24133407
references.citation: Obesity (Silver Spring). 2009 Mar;17(3):494-503
references.pmid: 19057523
references.citation: Dig Dis Sci. 1993 Apr;38(4):665-73
references.pmid: 8462365
references.citation: Scand J Gastroenterol. 1996 Jul;31(7):665-70
references.pmid: 8819215
references.citation: Am J Physiol Regul Integr Comp Physiol. 2013 Jul 1;305(1):R68-77
references.pmid: 23616105
references.citation: Exp Diabetes Res. 2012;2012:672658
references.pmid: 22675341
references.citation: Trends Endocrinol Metab. 2013 Feb;24(2):85-91
references.pmid: 23332584
references.citation: Diabetes Care. 2005 May;28(5):1092-100
references.pmid: 15855572
references.citation: Int J Obes (Lond). 2012 Jun;36(6):843-54
references.pmid: 21844879
references.citation: Endocrinology. 2011 Aug;152(8):3103-12
references.pmid: 21693680
references.citation: J Comp Neurol. 1999 Jan 11;403(2):261-80
references.pmid: 9886047
references.citation: Obesity (Silver Spring). 2008 Oct;16(10):2323-30
references.pmid: 18719634
references.citation: Auton Neurosci. 2004 Jan 30;110(1):36-43
references.pmid: 14766323
references.citation: Lancet. 2008 Oct 4;372(9645):1240-50
references.pmid: 18782641
references.citation: Lancet. 2009 Jul 4;374(9683):39-47
references.pmid: 19515413
references.citation: Diabetes. 2014 Apr;63(4):1422-7
references.pmid: 24379349
references.citation: Endocrinology. 2012 Feb;153(2):647-58
references.pmid: 22128031
references.citation: Endocrinology. 2007 Oct;148(10):4965-73
references.pmid: 17584962
references.citation: Core Evid. 2015 Jan 09;10:11-21
references.pmid: 25657615
references.citation: Orthop Clin North Am. 2011 Jan;42(1):95-105, vii
references.pmid: 21095438
references.citation: Int J Obes (Lond). 2014 May;38(5):689-97
references.pmid: 23942319
references.citation: Diabetes Care. 2009 Jul;32(7):1224-30
references.pmid: 19289857
references.citation: Diabetes. 2007 Jan;56(1):8-15
references.pmid: 17192459
references.citation: Expert Opin Drug Saf. 2015 Feb;14(2):207-18
references.pmid: 25496749
references.citation: Diabetes. 2006 Dec;55(12):3387-93
references.pmid: 17130484
references.citation: Neuroscience. 1997 Mar;77(1):257-70
references.pmid: 9044391
references.citation: Reproduction. 2010 Sep;140(3):399-410
references.pmid: 20802107
references.citation: Peptides. 2014 Aug;58:1-6
references.pmid: 24879927
references.citation: JAMA Surg. 2014 Dec;149(12):1323-9
references.pmid: 25271405
references.citation: Diabetes Res Clin Pract. 2012 Aug;97(2):258-66
references.pmid: 22446097
references.citation: Diabetes. 2014 Oct;63(10):3346-58
references.pmid: 24917578
references.citation: J Neurosci. 2011 Oct 12;31(41):14453-7
references.pmid: 21994361
references.citation: Neuropsychiatr Dis Treat. 2014 Oct 03;10:1897-902
references.pmid: 25336955
references.citation: Am J Physiol Endocrinol Metab. 2013 Dec 1;305(11):E1367-74
references.pmid: 24105414
references.citation: Diabetes Obes Metab. 2015 Mar;17(3):285-93
references.pmid: 25475828
references.citation: Curr Opin Endocrinol Diabetes Obes. 2015 Feb;22(1):21-8
references.pmid: 25517025
references.citation: Exp Diabetes Res. 2011;2011:279530
references.pmid: 21747825